Rankings
▼
Calendar
FDMT Q2 2018 Earnings — 4D Molecular Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FDMT
4D Molecular Therapeutics, Inc.
$427M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
-$2M
-61.9% margin
Operating Income
-$3M
-105.3% margin
Net Income
-$3M
-102.3% margin
EPS (Diluted)
$-0.52
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$201,500
← FY 2018
All Quarters
Q3 2018 →
